Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi Environmental & Social Information 2009

Sep 21, 2009

1643_rns_2009-09-21_312db11e-a30a-4e72-aee6-917148527d3a.pdf

Environmental & Social Information

Open in viewer

Opens in your device viewer

Sanofi-aventis receives renewed recognition as a leader in sustainability

Paris, France – September 21, 2009 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has been listed for the third consecutive year, on the Dow Jones Sustainability Index (DJSI World), the most important international sustainability index in terms of capital investment.

"Sanofi-aventis is proud of this success, which is a tribute to all our employees and their involvement on a daily basis. Sustainability, as an integral part of our corporate strategy, becomes a reality in our business activities and our economic, social, societal and environmental commitments," said Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis. "This commitment has been strengthened by the creation of a Corporate Social Responsibility Department, which will play an active part in achieving sanofi-aventis' ambition: building a global healthcare leader focused on patients' needs."

The DJSI World features approximately 10% of the top-performing companies in sustainability, among 2500 worldwide.

This Index assesses companies' economic, social, societal and environmental performance in 24 distinct areas. These include, among others, corporate governance, combating climate change, social dialogue and innovation, access to medicines and healthcare, relationships with suppliers, ethics in research and responsible marketing.

The accomplishments that enabled sanofi-aventis to excel in these various areas may be viewed on the Group's Sustainability website: http://sustainability.sanofi-aventis.com

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).